Jason Stacy, MD
Neurological Surgery · Jackson, MSNPI 1154559961
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,255 of the $27,685 with a category attached, or 80.4%. AstraZeneca accounts for 80.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $8,923 and has fallen 92.8% since, to $643 in 2025. Among neurological surgery clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $187.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$22K
- Medtronic$3K
- Si-bone, Inc.$346
- Stryker$296
- Penumbra, Inc.$221
- Irras USA, Inc.$155
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$22,25580%
- Travel & lodging$1,1914%
- Food & beverage$4,23815%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 35 | $22,193 |
| Medtronic(2 entities) | 40 | $3,177 |
| Si-bone, Inc. | 13 | $346 |
| Stryker | 6 | $296 |
| Penumbra, Inc. | 2 | $221 |
| Irras USA, Inc. | 1 | $155 |
| Providence Medical Technology, Inc. | 7 | $129 |
| Johnson & Johnson | 4 | $116 |
| CSL Behring | 3 | $113 |
| Portola Pharmaceuticals, LLC | 5 | $112 |
| Arbor Pharmaceuticals, Inc. | 6 | $100 |
| Balt USA, LLC | 1 | $98 |
| Orthofix Medical, Inc. | 3 | $82 |
| Vertex | 5 | $73 |
| Zimmer Biomet | 1 | $73 |
| Microvention, Inc. | 1 | $56 |
| Chiesi USA, Inc. | 3 | $45 |
| Cerapedics Inc. | 1 | $43 |
| Imperative Care, Inc | 1 | $39 |
| Biocomposites Inc | 2 | $36 |
| Arkis Biosciences Inc | 1 | $34 |
| Smith+Nephew | 2 | $34 |
| Baxter Healthcare | 1 | $34 |
| Integra Lifesciences Corporation | 1 | $27 |
| Qapel Medical Inc | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Intrinsic Therapeutics | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$21,663
- Pipeline$1,876
- IRRASflow$155
- Penumbra System$124
- INTELLIS ADAPTIVESTIM$109
- TARGET$107
- SOLITAIRE X$107
How this compares
$27,685 in reported general payments places this provider in the 90th percentile of 54 neurological surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 42 | $19,442 |
| Amitriptyline Hcl | 101 | $1,183 |
| Celecoxib | 35 | $1,110 |
| Gabapentin | 117 | $1,016 |
| Duloxetine Hcl | 92 | $840 |
| Prasugrel Hcl | 18 | $623 |
| Pregabalin | 18 | $446 |
| Meloxicam | 75 | $251 |
| Baclofen | 14 | $236 |
| Levetiracetam | 14 | $150 |
| ClopidogrelClopidogrel Bisulfate | 18 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $22,193 | $19,44242 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 54 neurological surgery providers in Mississippi.
Other neurological surgery in Jackson
- Allison StricklandJackson$75K
- Menarvia GaddisJackson$23K
- Brandon BurnsedJackson$7K
- Andrew SmithJackson$5K
- Haynes HarkeyJackson$5K
- Kathryn LucasJackson$4K
- Roberto Rey DiosJackson$4K
- Bryan GaspardJackson$3K
- John LanconJackson$3K
- Muhammad ChohanJackson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.